Home LiteratureArticle Details
PMID: 4734403 Published · ppublish English Journal Article

The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum.

The Journal of experimental medicine ·Vol. 137 ·No. 2 ·1973-02-01 ·Pages 424-37

Alper CA, Goodkofsky I, Lepow IH

Abstract

Factor B activity of the properdin system was found to be identical with purified glycine-rich beta-glycoprotein (GBG) but was distinct from the normal human serum protein capable of forming a C3-inactivating complex with a protein from cobra venom (CoF). Factor B activity coincided with electrophoretically separated GBG genetic variants, whereas the CoF-binding protein did not. GBGase destroyed factor B as it cleaved GBG but did not destroy the C3-inactivating activity of the CoF-binding protein. During incubation of serum with CoF, GBG did not change in molecular size, nor was there any coincidence in the immunoelectrophoretic mobilities of CoF and GBG. It was not possible to precipitate labeled CoF incubated with serum by anti-GBG, nor labeled GBG from serum incubated with CoF by anti-CoF. The CoF-binding capacity of serum was 2 mg/100 ml or less or under 6.5% of the serum concentration of GBG. When labeled CoF was added to serum below the binding capacity, complete complexation of the CoF was demonstrated, whereas CoF was largely uncomplexed when CoF was added in amounts equimolar to GBG.

MeSH Terms
Animals Autoradiography Complement Inactivator Proteins Electrophoresis Glycine Glycoproteins Humans Immune Sera Iodine Isotopes Properdin Serum Globulins Snakes Solubility Venoms
Chemicals
Complement Inactivator Proteins Glycoproteins Immune Sera Iodine Isotopes Serum Globulins Venoms Properdin Glycine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Alper C A
Goodkofsky I
Lepow I H
References (22)
22 references, click to expand
  1. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.
    Science. 1954 Aug 20;120(3112):279-85 PMID: 13186838
  2. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    J Exp Med. 1965 Aug 1;122:277-98 PMID: 14316946
  3. SNAKE VENOM IN RELATION TO HAEMOLYSIS, BACTERIOLYSIS, AND TOXICITY.
    J Exp Med. 1902 Mar 1;6(3):277-301 PMID: 19866973
  4. Isolation and properties of a glycine-rich gamma-glycoprotein of human serum.
    Biochim Biophys Acta. 1970 Jul 27;214(1):135-40 PMID: 4099040
  5. A new supporting medium for preparative electrophoresis.
    Scand J Clin Lab Invest. 1960;12:33-7 PMID: 13848687
  6. Genetic polymorphism of the third component of human complement (C'3).
    J Clin Invest. 1968 Sep;47(9):2181-91 PMID: 5675433
  7. The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system.
    Z Immun exp ther. 1959 Oct-Nov;118:349-57 PMID: 13801696
  8. The properdin system and immunity. V. The bactericidal activity of the properdin system.
    J Exp Med. 1956 May 1;103(5):553-75 PMID: 13319578
  9. Functional relationship of factor B in the properdin system to C3 proactivator of human serum.
    J Immunol. 1971 Oct;107(4):1200-4 PMID: 5093780
  10. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.
    Anal Biochem. 1966 Apr;15(1):45-52 PMID: 5959431
  11. Isolation and properties of a glycine-rich beta-glycoprotein of human serum.
    Biochim Biophys Acta. 1970 Dec 22;221(3):529-35 PMID: 5499437
  12. Multiple nature of the third component of guinea-pig complement. I. Separation and characterization of three factors a, b, and c, essential for haemolysis.
    Immunology. 1965 Jun;8(6):590-603 PMID: 5891628
  13. A molecular concept of immune cytolysis.
    Arch Pathol. 1966 Sep;82(3):205-17 PMID: 5329367
  14. Hemolytic efficiencies of genetic variants of human C3.
    J Immunol. 1972 May;108(5):1184-7 PMID: 5029137
  15. [Immunoelectrophoretic method for the analysis of mixtures of antigenic substances].
    Biochim Biophys Acta. 1955 May;17(1):67-74 PMID: 13239629
  16. [Isolation and properties of a beta-glycoprotein from human serum].
    Clin Chim Acta. 1965 Oct;12(4):419-24 PMID: 5847757
  17. Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection.
    J Clin Invest. 1970 Nov;49(11):1975-85 PMID: 4097977
  18. The properdin system and immunity. XII. Assay, properties and partial purification of a hydrazine-sensitive serum factor (factor A) in the properdin system.
    Z Immun exp ther. 1959 Oct-Nov;118:329-48 PMID: 14431638
  19. Genetic polymorphism in human glycine-rich beta-glycoprotein.
    J Exp Med. 1972 Jan;135(1):68-80 PMID: 4109808
  20. A new type of inherited serum albumin anomaly.
    J Clin Invest. 1966 Dec;45(12):1935-45 PMID: 5926635
  21. Genetic aspects of the complement system.
    Adv Immunol. 1971;14:251-90 PMID: 5003195
  22. A new concept of immunosuppression in hypersensitivity reactions and in transplantation immunity.
    Surv Ophthalmol. 1966 Aug;11(4):498-505 PMID: 5919620
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1973-02-01
Pages
424-37
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2139488
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com